Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present MusclePharm Corp. (OTC: MSLP).

Full DD Report for MSLP

You must become a subscriber to view this report.


Recent News from (OTC: MSLP)

MusclePharm Corporation's (MSLP) CEO Ryan Drexler on Q2 2018 Results - Earnings Call Transcript
MusclePharm Corporation (MSLP) Q2 2018 Results Earnings Conference Call August 14, 2018, 04:30 PM ET Executives Kevin McCabe - Investor Relations Contact, LHA Investor Relations Ryan Drexler - Chairman, President and Chief Executive Officer Kevin Harris - Interim Chief Financial ...
Source: SeekingAlpha
Date: August, 14 2018 21:15
MusclePharm Corporation Reports Second Quarter 2018 Financial Results
- Achieves Third Consecutive Quarter of Sequential Revenue Growth - Conference call begins at 4:30 p.m. Eastern time today BURBANK, CA / ACCESSWIRE / August 14, 2018 / MusclePharm® Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically driven, performance-life...
Source: ACCESSWIRE
Date: August, 14 2018 16:05
MusclePharm(R) Corporation to Hold 2018 Second Quarter Conference Call on August 14, 2018
BURBANK, CA / ACCESSWIRE / August 7, 2018 / MusclePharm® Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, will report financial results for the three and six months ended June 30, 2018 after market close on Tuesday, August 14, 2018. Mus...
Source: ACCESSWIRE
Date: August, 07 2018 08:30
MusclePharm Corporation to Present at the 8th Annual LD Micro Invitational Conference on June 5
BURBANK, CA / ACCESSWIRE / May 29, 2018 / MusclePharm® Corporation (OTCQB: MSLP) (''MusclePharm'' or the ''Company''), a scientifically driven, performance-lifestyle sports nutrition company, announces that Ryan Drexler, President and Chief Executive Officer, will present at the 8th ann...
Source: ACCESSWIRE
Date: May, 29 2018 08:30
MusclePharm Corporation Reports First Quarter 2018 Financial Results
Advances Toward Profitability with Second Consecutive Quarter of Sequential Revenue Growth and Narrowed Operating Loss Conference Call Begins at 4:30 p.m. Eastern Time Today BURBANK, CA / ACCESSWIRE / May 14, 2018 / MusclePharm ® Corporation (OTCQB: MSLP) ("MusclePharm" or t...
Source: ACCESSWIRE
Date: May, 14 2018 16:05
MusclePharm Corporation to Hold First Quarter 2018 Conference Call on May 14, 2018
BURBANK, CA / ACCESSWIRE / May 7, 2018 / MusclePharm ® Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, will report financial results for the three months ended March 31, 2018 after market close on Monday, May 14, 2018. MusclePharm man...
Source: ACCESSWIRE
Date: May, 07 2018 16:05
FDA cracks down on caffeine supplements
The FDA announces that it issued new guidance on high levels of caffeine in supplements. More news on: GNC Holdings, Inc., MusclePharm Corp., Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: April, 13 2018 12:54
MusclePharm's (MSLP) CEO Ryan Drexler on Q4 2017 Results - Earnings Call Transcript
MusclePharm Corporation (MSLP) Q4 2017 Results Earnings Conference Call March 28, 2018 04:30 PM ET Executives Jody Cain - LHA, IR Ryan Drexler - Chairman, President and CEO Brian Casutto - EVP, Sales and Operations Kevin Harris - Interim CFO Matt Kerbel - Chief Marketing Offi...
Source: SeekingAlpha
Date: March, 28 2018 19:55
MusclePharm Corporation Reports 2017 Fourth Quarter and Full Year Financial Results
Fourth Quarter Revenue Increases and Operating Loss Narrows Compared with the Third Quarter as Company Makes Progress Toward Sustained Profitable Growth Conference Call Begins at 4:30 pm Eastern Time Today BURBANK, CA / ACCESSWIRE / March 28, 2018 / MusclePharm® Corporation ...
Source: ACCESSWIRE
Date: March, 28 2018 16:05
MusclePharm Corporation to Hold 2017 Fourth Quarter and Full Year Conference Call on March 28, 2018
MusclePharm ® Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, will report financial results for the three and twelve months ended December 31, 2017 after market close on Wednesday, March 28, 2018. MusclePharm management will hold an i...
Source: Business Wire
Date: March, 22 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-120.900.900.900.9023,300
2018-12-110.980.900.980.8965,260
2018-12-100.890.980.980.897,377
2018-12-070.990.890.990.893,342
2018-12-060.920.991.000.928,713

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1122,00065,26033.7113Cover
2018-12-102,0007,37727.1113Cover
2018-12-072,0003,34259.8444Short
2018-12-061,1008,71312.6248Cover
2018-12-04301,8351.6349Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MSLP.


About MusclePharm Corp. (OTC: MSLP)

Logo for MusclePharm Corp. (OTC: MSLP)

Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding international healthy life style company that develops and manufactures a full line of NSF and scientifically approved nutritional supplements that are free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six stage research protocol involving the expertise of top nutritional scientists, and field tested by more than elite professional athletes from various sports including the NFL, MMA, and MLB. The Company s propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm products are sold in over countries and available in over , U.S. retail outlets that include GNC. Costco and Vitamin Shoppe, as well as over online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit www.musclepharm.com.

 

 

 

Current Management

  • Ryan Drexler / CEO, President
  • Brian Casutto / EVP, Sales
  • Megan Carley / Controller

Current Share Structure

  • Market Cap: $13,718,673 - 03/15/2018
  • Authorized: 100,000,000 - 03/15/2018
  • Issue and Outstanding: 15,951,945 - 03/15/2018
  • Float: 11,674,260 - 03/22/2017

 


Recent Filings from (OTC: MSLP)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 14 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: January, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 19 2017
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: December, 04 2017
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: November, 16 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 14 2017

 

 


Daily Technical Chart for (OTC: MSLP)

Daily Technical Chart for (OTC: MSLP)


Stay tuned for daily updates and more on (OTC: MSLP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MSLP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MSLP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MSLP and does not buy, sell, or trade any shares of MSLP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/